KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Gsk (GSK) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to $3.7 billion.

  • Gsk's Income from Continuing Operations rose 446187.52% to $3.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 billion, marking a year-over-year increase of 3917.9%. This contributed to the annual value of $3.8 billion for FY2024, which is 4286.48% down from last year.
  • Gsk's Income from Continuing Operations amounted to $3.7 billion in Q3 2025, which was up 446187.52% from $2.8 billion recorded in Q2 2025.
  • In the past 5 years, Gsk's Income from Continuing Operations ranged from a high of $5.8 billion in Q4 2023 and a low of $81.9 million during Q3 2024
  • In the last 5 years, Gsk's Income from Continuing Operations had a median value of $2.6 billion in 2023 and averaged $2.5 billion.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first tumbled by 9684.46% in 2024, then skyrocketed by 446187.52% in 2025.
  • Quarter analysis of 5 years shows Gsk's Income from Continuing Operations stood at $250.7 million in 2021, then skyrocketed by 1629.48% to $4.3 billion in 2022, then skyrocketed by 33.09% to $5.8 billion in 2023, then decreased by 24.92% to $4.3 billion in 2024, then decreased by 13.82% to $3.7 billion in 2025.
  • Its Income from Continuing Operations was $3.7 billion in Q3 2025, compared to $2.8 billion in Q2 2025 and $3.1 billion in Q1 2025.